High-risk Influenza Vaccine Alert

NACompletedINTERVENTIONAL
Enrollment

80,452

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Influenza
Interventions
BEHAVIORAL

Alert

Non-interruptive best practice alert in the electronic health record

BEHAVIORAL

Salient alert features

Larger alert header and body font size, use of different font colors and boldface

BEHAVIORAL

High-risk Text

Alert header indicates patient is at high risk for flu and its complications; alert body indicates the percentage of risk (e.g., in the top 3% of risk)

BEHAVIORAL

Risk factors

Alert body indicates the top 3 factors contributing to the high risk

Trial Locations (1)

17822

Geisinger Clinic, Danville

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Massachusetts Institute of Technology

OTHER

collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Bureau of Economic Research, Inc.

OTHER

lead

Geisinger Clinic

OTHER

NCT05492786 - High-risk Influenza Vaccine Alert | Biotech Hunter | Biotech Hunter